Compare · head to head
Moderna vs Novavax
Novavax ranks higher overall — 360 rank 23 vs 20.
Novavax leads on Value (58 vs 43) and Quality (60 vs 39). Moderna leads on Growth (46 vs 26), Safety (39 vs 31) and Sentiment (49 vs 44).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology |
| Size | X-Large | Medium |
| ISIN | US60770K1079 | US6700024010 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 20 | 23 |
| Value | 43 | 58 |
| Quality | 39 | 60 |
| Growth | 46 | 26 |
| Safety | 39 | 31 |
| Sentiment | 49 | 44 |
| Quality details | ||
| Profitability | 24 | 67 |
| Cash Truth | 53 | 53 |
Moderna vs Maravai LifeSciences HoldingsModerna vs Enanta PharmaceuticalsModerna vs Sarepta TherapeuticsModerna vs Mirum PharmaceuticalsAdd a third stock →
Full analyses: Moderna · Novavax
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100